Jin Chunxiang, Naruse Satoru, Kitagawa Motoji, Ishiguro Hiroshi, Muxin Wei, Nakajima Morio, Yokohata Koji, Ito Osamu, Hayakawa Tetsuo
Internal Medicine II, Nagoya University School of Medicine, Nagoya, Japan.
Gastroenterology. 2002 Nov;123(5):1578-87. doi: 10.1053/gast.2002.36584.
BACKGROUND & AIMS: Gastric blood flow exhibits cyclical increases in phase with the interdigestive contractions and secretion of the stomach in dogs. The aim of this study is to clarify the regulatory role of motilin in interdigestive gastric blood flow in dogs.
Blood flow of the left gastric (LGA) and superior mesenteric (SMA) arteries were measured by ultrasound transit-time blood-flow meters in 5 conscious dogs. Motilin was infused intravenously with or without Phe-cyclo[Lys-Tyr(3-tBu)-betaAla-]. trifluoroacetate (GM-109; motilin antagonist), granisetron (5-HT3 antagonist), atropine, hexamethonium (C6), phenoxybenzamine, propranolol, or cimetidine.
Motilin (12.5, 25, 50, and 100 pmol x kg(-1) x h(-1)) induced LGA blood-flow responses, consisting of a sustained increase and a rapid phasic change coupled with a contraction, without affecting the blood pressure, heart rate, and SMA blood flow. GM-109 completely abolished the LGA, motility, and secretory responses to motilin (100 pmol x kg(-1) x h(-1)). Atropine abolished motilin-induced gastric contractions, secretion, and phasic changes of LGA blood flow but failed to affect the sustained flow increase. However, atropine partially inhibited the LGA responses to lower doses of motilin. The LGA flow responses to motilin were not inhibited by granisetron, C6, alpha-adrenergic, beta-adrenergic, or H2 blockers. Motilin induced significantly larger gastric vasodilatation than the equivalent doses of VIP.
Motilin has a potent and selective gastric vasodilator effect, which appears to be mediated by both cholinergic and noncholinergic mechanisms. Motilin plays an important role in the regulation of interdigestive gastric blood flow in dogs.
犬胃血流量随胃消化间期收缩和分泌呈周期性增加。本研究旨在阐明胃动素在犬消化间期胃血流量调节中的作用。
用超声渡越时间血流仪测量5只清醒犬的胃左动脉(LGA)和肠系膜上动脉(SMA)的血流量。静脉注射胃动素,同时或不联合苯丙氨酸环[赖氨酸-酪氨酸(3-叔丁基)-β丙氨酸]·三氟乙酸盐(GM-109;胃动素拮抗剂)、格拉司琼(5-羟色胺受体3拮抗剂)、阿托品、六甲铵(C6)、酚苄明、普萘洛尔或西咪替丁。
胃动素(12.5、25、50和100 pmol·kg⁻¹·h⁻¹)引起LGA血流反应,包括持续增加和与收缩相关的快速相位变化,且不影响血压、心率和SMA血流。GM-109完全消除了LGA、运动和分泌对胃动素(100 pmol·kg⁻¹·h⁻¹)的反应。阿托品消除了胃动素诱导的胃收缩、分泌和LGA血流的相位变化,但未能影响血流的持续增加。然而,阿托品部分抑制了较低剂量胃动素引起的LGA反应。格拉司琼、C6、α-肾上腺素能、β-肾上腺素能或H2受体阻滞剂均未抑制胃动素引起的LGA血流反应。与同等剂量的血管活性肠肽相比,胃动素诱导的胃血管舒张作用明显更强。
胃动素具有强大且选择性的胃血管舒张作用,这似乎是由胆碱能和非胆碱能机制介导的。胃动素在犬消化间期胃血流量调节中起重要作用。